Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

292,816 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Immune response and homeostasis mechanism following administration of BBIBP-CorV SARS-CoV-2 inactivated vaccine.
Yin J, Zhao Y, Huang F, Yang Y, Huang Y, Zhuang Z, Wang Y, Wang Z, Lin X, Zheng Y, Zhou W, Wang S, Xu Z, Ye B, Guo Y, Lei W, Li L, Tian J, Gan J, Wang H, Wang W, Ma P, Liu C, Wei X, Shi X, Wang Z, Wang Y, Liu Y, Yang M, Yuan Y, Song Y, Ma W, Huang Z, Liu Y, Huang Y, Lu H, Liu P, Liang H, Hou Y, Xu X, Liu L, Zhang Y, Wu G, Gao GF, Jin X, Liu C, Yang X, Liu WJ. Yin J, et al. Among authors: wang h, wang w, wang z, wang y, wang s. Innovation (Camb). 2023 Jan 30;4(1):100359. doi: 10.1016/j.xinn.2022.100359. Epub 2022 Dec 5. Innovation (Camb). 2023. PMID: 36506806 Free PMC article.
Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes: Interim Analysis of 2 Randomized Clinical Trials.
Xia S, Duan K, Zhang Y, Zhao D, Zhang H, Xie Z, Li X, Peng C, Zhang Y, Zhang W, Yang Y, Chen W, Gao X, You W, Wang X, Wang Z, Shi Z, Wang Y, Yang X, Zhang L, Huang L, Wang Q, Lu J, Yang Y, Guo J, Zhou W, Wan X, Wu C, Wang W, Huang S, Du J, Meng Z, Pan A, Yuan Z, Shen S, Guo W, Yang X. Xia S, et al. Among authors: wang x, wang w, wang z, wang y, wang q. JAMA. 2020 Sep 8;324(10):951-960. doi: 10.1001/jama.2020.15543. JAMA. 2020. PMID: 32789505 Free PMC article. Clinical Trial.
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial.
Xia S, Zhang Y, Wang Y, Wang H, Yang Y, Gao GF, Tan W, Wu G, Xu M, Lou Z, Huang W, Xu W, Huang B, Wang H, Wang W, Zhang W, Li N, Xie Z, Ding L, You W, Zhao Y, Yang X, Liu Y, Wang Q, Huang L, Yang Y, Xu G, Luo B, Wang W, Liu P, Guo W, Yang X. Xia S, et al. Among authors: wang h, wang w, wang y, wang q. Lancet Infect Dis. 2021 Jan;21(1):39-51. doi: 10.1016/S1473-3099(20)30831-8. Epub 2020 Oct 15. Lancet Infect Dis. 2021. PMID: 33069281 Free PMC article. Clinical Trial.
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18 years or older: A randomized, double-blind, placebo-controlled, phase 1/2 trial.
Guo W, Duan K, Zhang Y, Yuan Z, Zhang YB, Wang Z, Zhao D, Zhang H, Xie Z, Li X, Peng C, Zhang W, Yang Y, Chen W, Gao X, You W, Wang XW, Shi Z, Wang Y, Yang XQ, Zhang L, Huang L, Wang Q, Lu J, Yang YL, Guo J, Zhou W, Wan X, Wu C, Wang W, Du J, Nian X, Li XH, Huang S, Shen S, Xia S, Pan A, Yang X. Guo W, et al. Among authors: wang w, wang xw, wang z, wang y, wang q. EClinicalMedicine. 2021 Aug;38:101010. doi: 10.1016/j.eclinm.2021.101010. Epub 2021 Jul 7. EClinicalMedicine. 2021. PMID: 34250456 Free PMC article.
Safety and immunogenicity of an inactivated COVID-19 vaccine, BBIBP-CorV, in people younger than 18 years: a randomised, double-blind, controlled, phase 1/2 trial.
Xia S, Zhang Y, Wang Y, Wang H, Yang Y, Gao GF, Tan W, Wu G, Xu M, Lou Z, Huang W, Xu W, Huang B, Wang W, Zhang W, Li N, Xie Z, Zhu X, Ding L, You W, Zhao Y, Zhao J, Huang L, Shi X, Yang Y, Xu G, Wang W, Liu P, Ma M, Qiao Y, Zhao S, Chai J, Li Q, Fu H, Xu Y, Zheng X, Guo W, Yang X. Xia S, et al. Among authors: wang h, wang w, wang y. Lancet Infect Dis. 2022 Feb;22(2):196-208. doi: 10.1016/S1473-3099(21)00462-X. Epub 2021 Sep 15. Lancet Infect Dis. 2022. PMID: 34536349 Free PMC article. Clinical Trial.
Safety and Immunogenicity of an Inactivated COVID-19 Vaccine, WIBP-CorV, in Healthy Children: Interim Analysis of a Randomized, Double-Blind, Controlled, Phase 1/2 Trial.
Xia S, Duan K, Zhang Y, Zeng X, Zhao D, Zhang H, Xie Z, Li X, Peng C, Zhang W, Yang Y, Chen W, Gao X, You W, Wang X, Wang Z, Shi Z, Wang Y, Yang X, Li Q, Huang L, Wang Q, Lu J, Yang Y, Guo J, Zhou W, Wan X, Wu C, Wang W, Huang S, Du J, Nian X, Deng T, Yuan Z, Shen S, Guo W, Liu J, Yang X. Xia S, et al. Among authors: wang x, wang w, wang z, wang y, wang q. Front Immunol. 2022 Jun 24;13:898151. doi: 10.3389/fimmu.2022.898151. eCollection 2022. Front Immunol. 2022. PMID: 35812412 Free PMC article. Clinical Trial.
Safety and immunogenicity of rabies vaccine (PVRV-WIBP) in healthy Chinese aged 10-50 years old: Randomized, blinded, parallel controlled phase III clinical study.
Huang X, Liang J, Huang L, Nian X, Chen W, Zhang J, Xu X, Lin X, Wang Y, Shi J, Jia L, Li Q, Wang Q, Duan K, Li X, Ji Y, Peng F, Zhang W, Xie Z, Wang Y, Yang X. Huang X, et al. Among authors: wang y, wang q. Hum Vaccin Immunother. 2023 Dec 31;19(1):2211896. doi: 10.1080/21645515.2023.2211896. Epub 2023 May 30. Hum Vaccin Immunother. 2023. PMID: 37249318 Free PMC article. Clinical Trial.
Safety and immunogenicity of a quadrivalent inactivated subunit non-adjuvanted influenza vaccine: A randomized, double-blind, active-controlled phase 1 clinical trial.
Wang Y, Zhang Y, Wu H, Huang L, Yu H, Xie Z, Zhang H, Zhang W, Chen X, Zhang H, Zhang H, Jia C, Xia S, Wang S. Wang Y, et al. Among authors: wang s. Vaccine. 2021 Jun 29;39(29):3871-3878. doi: 10.1016/j.vaccine.2021.05.070. Epub 2021 Jun 1. Vaccine. 2021. PMID: 34088505 Free article. Clinical Trial.
[Immunogenicity of group A+C meningococcal polysaccharide conjugate vaccine in infants: A phase Ⅲ clinical trial study].
Huang LL, Ma XM, Huang HT, Xie ZQ, Gou JB, Yang YL, Wang X, Zhang W, You WY, Tan JB, Xu LF, Feng GW, Zhu T, Wang Y. Huang LL, et al. Among authors: wang x, wang y. Zhonghua Yu Fang Yi Xue Za Zhi. 2022 Dec 6;56(12):1728-1733. doi: 10.3760/cma.j.cn112150-20211206-01124. Zhonghua Yu Fang Yi Xue Za Zhi. 2022. PMID: 36536558 Clinical Trial. Chinese.
292,816 results
You have reached the last available page of results. Please see the User Guide for more information.